Chloramphenicol eye drops: a dangerous drug?
Diamond, J.; Leeming, J.
Practitioner 239(1555): 608-611
1995
ISSN/ISBN: 0032-6518 PMID: 7494790 Document Number: 451046
Document emailed within 1 workday
Related Documents
Verin, P.; Easty, D.L.; Secchi, A.; Ciprandi, G.; Partouche, P.; Nemeth-Wasmer, G.; Brancato, R.; Harrisberg, C.J.; Estivin-Ebrardt, C.; Coster, D.J.; Apel, A.J.; Coroneo, M.T.; Knorr, M.; Carmichael, T.R.; Kent-Smith, B.T.; Abrantes, P.; Leonardi, A.; Cerqueti, P.M.; Modorati, G.; Martinez, M. 2001: Clinical evaluation of twice-daily emedastine 0.05% eye drops (emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis American Journal of Ophthalmology 131(6): 691-698Szukaj, M. 1994: MDMA ("Ecstasy")--a dangerous drug or psychotherapeutic drug? Der Nervenarzt 65(11): 802-805
Zalzstein, E.; Lifshitz, M. 1985: Nasal drops as a cause of severe drug intoxication in infancy Harefuah 109(7-8): 189-190
Leino, M.; Carlson, C.; Jaanio, E.; Koivunen, T.; Lavikkala, H.; Riihelä, K.; Takalo, E. 1990: Double-blind group comparative study of 2% nedocromil sodium eye drops with placebo eye drops in the treatment of seasonal allergic conjunctivitis Annals of Allergy 64(4): 398-402
Miram, R. 1972: Determination and stability of chloramphenicol in drug preparations Pharmazeutische Praxis 5: 108-110
De Benedetti, E.; Urban, P. 2007: Are drug-eluting stents dangerous? Revue Medicale Suisse 3(102): 656-658
Torsti, P. 1971: Is acetylsalicylic acid a dangerous drug? Duodecim; Laaketieteellinen Aikakauskirja 87(7): 492-494
Astrup, N. 1992: India: an expensive and dangerous drug Sygeplejersken 92(51): 36-38
Persson, S.A.; Eriksson, A.; Hallgren, N.; Eklund, A.; Berkowicz, A.; Druid, H. 2001: GHB--dangerous, addictive and uncontrollable "party drug" Lakartidningen 98(38): 4026
Murray, T.R.; Downey, K.M.; Yunis, A.A. 1983: Chloramphenicol-mediated DNA damage and its possible role in the inhibitory effects of chloramphenicol on DNA synthesis Journal of Laboratory and Clinical Medicine 102(6): 926-932
Rivera, M.J.; Cabello, A.; Gomez-Lus, R. 1989: Chloramphenicol resistance in clinical isolates of enterobacteria: characterization of chloramphenicol acetyltransferases Journal of ChemoTherapy 1(4 Suppl): 309-310
Calderón, E.; Gilman, R.H.; Snyder, M.J.; Vázquez, V.; Barreto, D.G.; Legorreta, J.; Rodríguez, R.; Martínez, E.; Hornick, R.B.; Woodward, T.E. 1974: A controlled clinical trial of chloramphenicol in chloramphenicol-resistant typhoid fever Revista Latinoamericana de Microbiologia 16(3): 131-136
Markus, L. 2008: Flunitrazepame--report based on experience with a dangerous drug MMW Fortschritte der Medizin 150 Suppl. 1: 27-30
Edibam, E.; Vegad, J. 1970: Chloramphenicol with streptomycin, chloramphenicol with broxyquinoline and brobenzoxaldine suspension in diarrhoeas Indian Pediatrics 7(5): 281-285
Grieco, C.; Silipo, C.; Vittoria, A. 1975: Determination of chloramphenicol and vitamin C in drug combinations using gas chromatography and non-aqueous titrimetry Bollettino della Societa Italiana di Biologia Sperimentale 51(13): 817-823
Reinke, T. 2016: Boosting a Drug's Market Share Can Cross a Dangerous Line Managed Care 25(7): 36-39
Fausa, D.; Rasmussen, K. 1986: Amiodarone--a dangerous wonder drug. Review of the literature and personal experiences Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(5): 403-406
Yang, C; Southwell, B G. 2004: Dangerous disease, dangerous women: health, anxiety and advertising in Shanghai from 1928 to 1937 Critical Public Health 14(2): 149-156
Patanè, S.; Di Stefano, F.; Gatto, A. 1971: Drug interactions during therapy. Blood levels of chloramphenicol in animals pretreated with luminal as an enzyme inductor La Clinica Terapeutica 59(2): 137-141
Havelka, J. 1974: Interaction of chloramphenicol with food and effect of food on penetration of the chloramphenicol into bile Casopis Lekaru Ceskych 113(3): 79-82